1. Rationale and Clinical Research Progress on PD-1/PD-L1-Based Immunotherapy for Metastatic Triple-Negative Breast Cancer
   Yifan Ren et al, 2022, IJMS CrossRef
2. The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
   Wei Wang et al, 2022, Clin Transl Oncol CrossRef
3. Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance
   Roberto Campagna et al, 2023, Human Cell CrossRef
4. The effect of silencing the Tip60 gene on the response to radiotherapy in breast cancer cells
   Ece ser-Salihoğlu et al, 2023, The Breast CrossRef
5. The Value of Whole-Volume Radiomics Machine Learning Model Based on Multiparametric MRI in Predicting Triple-Negative Breast Cancer
   Tingting Xu et al, 2024, J Comput Assist Tomogr CrossRef
6. Clinical Outcomes and Predictors of Pathological Response in Triple Negative Breast Cancer Patients Receiving Anthracycline/Taxane-Based Neoadjuvant Therapy
   Mehmet Sabri Çiftçi et al, 2025, Indian J Surg CrossRef